Resources - Verilogue

Unpacking Vaccine Hesitancy: Perspectives at the Point of Care

Whitepaper

When the COVID-19 pandemic began in early 2020, there was widespread concern about how fast an effective vaccine could be developed – if one could be developed at all. As we move into Spring 2021 with multiple authorized vaccines on hand, the conversation has changed: the challenge expressed by public health experts is not whether there will be a vaccine, but whether people will be willing to take it.

We invite you to join our Linguistics Team as they share a glimpse into the current reality of the exam room that can fuel a more holistic understanding of the drivers of vaccine hesitancy, as well as meaningful solutions to overcome it.

DOWNLOAD NOW

Risk in the Age of COVID-19

Whitepaper

In the exam room, discussion of risks associated with COVID-19 are evolving as we learn more about the underlying characteristics of the virus and disease.

Through the analysis of exam room conversations with specific discussion of COVID-19, Verilogue compared HCP-PT conversations collected early in the pandemic against more recent conversations, exploring how discussions of risk evolved at the point of care and how the discussion is being shaped through education and research.

It is critical that this topic be well understood to ensure effective communication across stakeholders, and we invite you to explore the most prevalent themes in this new whitepaper.

DOWNLOAD NOW

The Oncology Patient Journey

Infographic

In this infographic, we dug deep into our database to determine which questions and roles pertained most to each HCP in an interactional standpoint.

DOWNLOAD NOW

Risk Communication Case Study

Case Study

In our newest Case Study, we analyze the techniques used by physicians to manage and communicate patient risk.

DOWNLOAD NOW

Cultural Communication Differences

Webinar

Whether it be different countries, religions, or races, people commonly stick to communicatory patterns when speaking about their health in their natural language. While these differences can have a negative impact on the patient during the diagnosis and treatment stage, there are opportunities for brands to support these patients locally and globally.

WATCH NOW